期刊文献+

前列腺素E_1治疗重型病毒性肝炎的临床观察 被引量:1

Evalution of Therapeutic Effect of Prostaglandin E_1 on Severe Viral Hepatitis
下载PDF
导出
摘要 目的 :探讨前列腺素E1治疗重型病毒性肝炎的临床疗效。方法 :6 0例重型病毒性肝炎患者随机分成治疗组 30例对照组 30例 ,对照组给予常规护肝 ,退黄及对症治疗 ,治疗组在给予常规对症治疗基础上 ,加用前列腺素E1(PGE1)静滴。观察疗效和不良反应。结果 :治疗组有效率为 76 .6 7% ,对照组为 4 6 .6 7%。治疗组胆红素降低明显优于对照组 ,肝肾综合症发生率明显低于对照组 (P <0 .0 5 ) ,不良反应轻微。结论 Objective: To investigate the therapeutic effect of prostagladin E 1 (PGE 1) on severe viral hepatitis.Methods: 60 severe viral hepatitis patients were divided into a treated group and a controlled group, each group consisted of 30 cases. The patients in the treated group received a combined routine therapy with venous infusion of prostaglandin E 1 (PGE 1), the patients in the contralled group received a routine therapy only.Result: The rate of cure and improvement in the treated group was 76.67% , that in the controlled group was 46.67% ( P < 0.05 ), The decrease of the total serum bilirubin in the treated group was more significant than the controlled group( P < 0.05 ), the incidence of hepatorenal syndrome in the treated group was less than the controlled group( P < 0.05 ). The side effects of prostaglandin E 1 were mild and could be tolerable.Conclusion: There is a marked difference between the groups. Prostaglandin E 1 is an effective and safe drug in the treatment of severe viral hepatitis.
出处 《中国药师》 CAS 2004年第5期372-374,共3页 China Pharmacist
关键词 前列腺素E1 肝炎 病毒性 重型 Prostaglandin E 1 Viral hepatitis,severe
  • 相关文献

参考文献10

  • 1病毒性肝炎防治方案[J].中华传染病杂志,2001,19(1):56-62. 被引量:1828
  • 2Achaya S K, Panda S K, Saxena A. et al. Acute hepatic failure in India: a perspective fron the East[J]. J GastroenterolHepatol,2000,15(4):473-479
  • 3Mizoguchi Y, Tsutsui H, Miyajima K, et al. The Protective effects of prostaglandin E1 in an experimental rassive hepatic cell necrosis model [J].Hepatology, 1987,7:1184
  • 4Stachura J, Tamawski A, Iuey KY, et al. Prostaglandin protection of carbon tetrachloride-induced liver cell necrosis in the rat[J]. Gastroenterology, 1981,81:211
  • 5Suzuki A, Hagino M, Yasuda N, et al. Inhibitory effects of prostaglandin E1 alpha-cyclodextrig (PG E1-CD) on dinethylnitrosamine indued acute liver damage in rats [J]. Nippon Yakurigaku zasshi, 1995,105(4) :221-229
  • 6刘沛,王兆荃,张捷,周子文,董祥家,大西弘生,武藤泰敏.前列腺素E_1治疗实验性肝坏死的机理研究[J].中华内科杂志,1994,33(4):241-243. 被引量:31
  • 7Effect of prostaglandin E1 and its initial metabolites on neutrophil-induced inhibition of human plateletaggregation [J]. Thromb Res. 1993,71:217-223
  • 8Ney P, Braunm, Szymanski, et al. Antiplatelet, antineutrophil and vasndilating properties of 13,14-Dihydro-PGE1-an in vivo metamolite of PGE1 in man[J].Endocrinology, 1991,4:177-182
  • 9MR Mehrabi, N Serbecic, F Tamadon, et al. Clinical benefit of Prostaglandin E1-treatnent of patients with ischemical heart disease: Stimulation of therapeutic agiogenesis in vital and infarcted myocardium [J], Bidmed Pharmacother,2003,57(3-4): 173-178
  • 10G Taveggia, L Selletti. Therapeutic effects of prostaglandin E1 in diabetic patients [J], Minerva Cardioangiol, 2003,51(3) :317-322

二级参考文献1

  • 1刘沛,Gastroenterologia Japonica,1990年,25卷,339页

共引文献1857

同被引文献17

  • 1张帮杰.前列地尔治疗重型肝炎疗效观察[J].临床医学,2004,24(8):32-32. 被引量:2
  • 2Egger M, Davey Smith G, Schneider M, et al. Bias in meta - analysis detected by a simple, graphical test. BMJ, 1997,315:629 -634
  • 3Sinclair SB,Greig PD, Blendis LM,et al. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E.A preliminary report. J Clin Invest, 1989,84 : 1063 - 1069
  • 4Bernaua J,Babany G,Bezeaud A,et al. Does prostaglandin El prevent further aggravation in severe or early fulminant hepatitis? A preliminary open trial E abstract]. J Hepatol, 1989,9 :S114
  • 5O'Brien C B,Henzel BS,Naji A, et al. Prostaglandin E1 infusions improve survival of patients with fulminant hepatic failure [abstract ].Gastroenterology, 1992,102 : A862
  • 6Sterling RK, Luketic VA,Sanyal A J, et al. Treatment of fulminant hepatic failure with intravenous prostaglandin E1.Liver Transpl Surg,1998,4:424 -431
  • 7Jadad AB,Moore BA,Carroll D,et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials,1996,17 :1 - 12
  • 8Sheiner P, Sinclair S, Greig P, et al. A randomized controlled trial of prostaglandin E in the treatment of fulminant hepatic failure [ abstract]. Hepatology, 1992,16:88A
  • 9刘毅,黄自存.前列腺素E_1在重型肝炎治疗中对细胞因子的影响[J].中西医结合肝病杂志,1997,7(4):239-240. 被引量:3
  • 10周霞秋,斯崇文,王兆荃,张定凤,朱理珉,巫善明,邬祥惠,林秀玉,徐道振.重型肝炎多中心药物治疗(附166例临床分析)[J].中华传染病杂志,1998,16(1):45-46. 被引量:56

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部